Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Anticancer Res. 2016 Dec;36(12):6449–6456. doi: 10.21873/anticanres.11243

Table V. Multivariate analysis of the association of E-cadherin and N-cadherin expression on overall survival.

Variable Hazard ratio (95% CI) p-Value*
Membranous E-cadherin Primary melanoma 5.06 (0.83-30.90) 0.080
Metastatic melanoma 3.01 (0.60-15.20) 0.180
Membranous N-cadherin Primary melanoma 0.31 (0.10-0.98) 0.046
Metastatic melanoma 1.79 (0.57-5.64) 0.320
Aberrant E-cadherin expression Primary melanoma 3.79 (1.13-12.72) 0.030
Metastatic melanoma 4.07 (1.01-16.38) 0.048
Switch from E-cadherin to N-cadherin Metastatic melanoma 0.23 (0.03-1.52) 0.130
Tumor depth Increasing 1.09 (1.00-1.19) 0.049
Gender Male vs. female 7.59 (1.90-30.40) 0.004
Age at diagnosis Increasing 0.99 (0.96-1.02) 0.560

CI: Confidence interval.

*

By Cox model.